Related Experiment Video
Updated: Sep 10, 2025

06:37
Embryo Microinjection and Knockout Mutant Identification of CRISPR/Cas9 Genome-Edited Helicoverpa Armigera Hübner
Published on: July 1, 2021
4.6K
Targeted Gene Editing in Honey Bees Using Liposome-Based CRISPR-Cas9.
Berkant İsmail Yıldız1, Kemal Karabağ2
1Department of Agricultural Biotechnology, Faculty of Agriculture, Akdeniz University, Antalya, Turkey.
Biochemical Genetics
|August 25, 2025
Summary
Researchers developed a new CRISPR-Cas9 delivery method using liposomes and drone sperm for honey bee gene editing. This efficient technique successfully created gene mutants, advancing apiculture and pollinator health research.
Area of Science:
- Molecular Biology
- Genetics
- Entomology
Background:
- Genome editing technologies offer precise gene function manipulation.
- CRISPR-Cas9 is a powerful tool for genetic modification.
- Honey bee research faces challenges with traditional embryo microinjection techniques.
Purpose of the Study:
- To introduce a novel liposome-mediated delivery system for CRISPR-Cas9 components.
- To target the Juvenile Hormone Acid Methyltransferase (JHAMT) gene in honey bees (Apis mellifera anatoliaca).
- To overcome limitations of honey bee embryo microinjection.
Main Methods:
- Utilized drone sperm cells as vectors for CRISPR-Cas9 transfection.
- Employed artificial insemination of queen bees with transfected sperm.
- Evaluated gene-editing efficiency across multiple generations.
Main Results:
- Successfully generated heterozygous and homozygous JHAMT mutants in honey bees.
- Achieved gene-editing efficiencies of approximately 43%.
- Demonstrated the viability of liposome-mediated delivery via sperm cells.
Conclusions:
- The novel liposome-mediated delivery system is efficient, non-invasive, and scalable for genome editing in eusocial insects.
- This method provides a viable alternative to traditional techniques in honey bee genetic research.
- Advances in genetic tools are crucial for apiculture and pollinator health.
Related Concept Videos
CRISPR/Cas9 Genome Editing
213
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
213
CRISPR
52.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.9K
CRISPR and crRNAs
17.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.4K

